Catalyst Wire Dossier Catalyst Wire Dossier

COVID-19 Vaccine Janssen

Ad26.COV2.S · Janssen Pharmaceuticals (Johnson & Johnson)
Drug timelines are a Plus or Pro feature.

13 regulatory and trial events tracked for COVID-19 Vaccine Janssen, covering 2021-02-16 to 2025-02-10. Get the full timeline:

Most recent: Clinical Trial Update: Cohort Assessing the Immunogenicity and the Safety of the COVID-19 Vaccine Janssen in Healthy Volunteers Based on 2 Age Groups: 65 Years or Older - 55 to 65 Years. Covicompare-Janssen [Phase 4]

See pricing